Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Frida Björk Gunnarsdottir, Nathalie Auoja, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö & Karin Leandersson. (2020) Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression. OncoImmunology 9:1.
Read now
Read now
Anna Ehinger, Per Malmström, Pär-Ola Bendahl, Christopher W. Elston, Anna-Karin Falck, Carina Forsare, Dorthe Grabau, Lisa Rydén, Olle Stål & Mårten Fernö. (2017) Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Acta Oncologica 56:1, pages 68-74.
Read now
Read now
Dorthe Aamand Grabau, Pär-Ola Bendahl, Lisa Rydén, Olle Stål & Mårten Fernö. (2013) The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval – prognostic implications?. Acta Oncologica 52:8, pages 1657-1666.
Read now
Read now
Articles from other publishers (33)
C Ingvar, J Ahlgren, S Emdin, L Lofgren, M Nordander, E Niméus & L-G Arnesson. (2020) Long-term outcome of pT1a–b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 women. British Journal of Surgery 107:10, pages 1299-1306.
Crossref
Crossref
Anna Ehinger, Pär-ola Bendahl, Lisa Rydén, Mårten Fernö & Sara Alkner. (2018) Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time. APMIS 126:9, pages 746-754.
Crossref
Crossref
Pernilla Roswall, Matteo Bocci, Michael Bartoschek, Hong Li, Glen Kristiansen, Sara Jansson, Sophie Lehn, Jonas Sjölund, Steven Reid, Christer Larsson, Pontus Eriksson, Charlotte Anderberg, Eliane Cortez, Lao H Saal, Christina Orsmark-Pietras, Eugenia Cordero, Bengt Kristian Haller, Jari Häkkinen, Ingrid J G Burvenich, Elgene Lim, Akira Orimo, Mattias Höglund, Lisa Rydén, Holger Moch, Andrew M Scott, Ulf Eriksson & Kristian Pietras. (2018) Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. Nature Medicine 24:4, pages 463-473.
Crossref
Crossref
Maria EkholmPär-Ola BendahlMårten FernöBo NordenskjöldOlle StålLisa Rydén. (2016) Two Years of Adjuvant Tamoxifen Provides a Survival Benefit Compared With No Systemic Treatment in Premenopausal Patients With Primary Breast Cancer: Long-Term Follow-Up (> 25 years) of the Phase III SBII:2pre Trial. Journal of Clinical Oncology 34:19, pages 2232-2238.
Crossref
Crossref
Rachel A. Sanford, Juhee Song, Angelica M. Gutierrez-Barrera, Jessica Profato, Ashley Woodson, Jennifer Keating Litton, Isabelle Bedrosian, Constance T. Albarracin, Vicente Valero & Banu Arun. (2015)
High incidence of germline
BRCA
mutation in patients with ER low-positive/PR low-positive/HER-2
neu
negative tumors
. Cancer 121:19, pages 3422-3427.
Crossref
Crossref
Maria V. Bogachek, Jung Min Park, James P. De Andrade, Mikhail V. Kulak, Jeffrey R. White, Tong Wu, Philip M. Spanheimer, Thomas B. Bair, Alicia K. Olivier & Ronald J. Weigel. (2014) A Novel Animal Model for Locally Advanced Breast Cancer. Annals of Surgical Oncology 22:3, pages 866-873.
Crossref
Crossref
Kristina E Aaltonen, Ann H Rosendahl, Hans Olsson, Per Malmström, Linda Hartman & Mårten Fernö. (2014) Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer. BMC Cancer 14:1.
Crossref
Crossref
Siker Kimbung, Anikó Kovács, Pär-Ola Bendahl, Per Malmström, Mårten Fernö, Thomas Hatschek & Ingrid Hedenfalk. (2013) Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences. Molecular Oncology 8:1, pages 119-128.
Crossref
Crossref
Carina Strand, Martin Bak, Signe Borgquist, Gunilla Chebil, Anna-Karin Falck, Marie-Louise Fjällskog, Dorthe Grabau, Ingrid Hedenfalk, Karin Jirström, Marie Klintman, Per Malmström, Hans Olsson, Lisa Rydén, Olle Stål, Pär-Ola Bendahl & Mårten Fernö. (2013) The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer. SpringerPlus 2:1.
Crossref
Crossref
Rebecca Ritte, Kaja Tikk, Annekatrin Lukanova, Anne Tjønneland, Anja Olsen, Kim Overvad, Laure Dossus, Agnès Fournier, Françoise Clavel-Chapelon, Verena Grote, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Franco Berrino, Amalia Mattiello, Rosario Tumino, Carlotta Sacerdote, José Ramón Quirós, Genevieve Buckland, Esther Molina-Montes, María-Dolores Chirlaque, Eva Ardanaz, Pilar Amiano, H Bas Bueno-de-Mesquita, Carla H van Gils, Petra HM Peeters, Nick Wareham, Kay-Tee Khaw, Timothy J Key, Ruth C Travis, Elisabete Weiderpass, Vanessa Dumeaux, Eliv Lund, Malin Sund, Anne Andersson, Isabelle Romieu, Sabina Rinaldi, Paulo Vineis, Melissa A Merritt, Elio Riboli & Rudolf Kaaks. (2013) Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer 13:1.
Crossref
Crossref
Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl & Lisa Rydén. (2013) St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial. BMC Cancer 13:1.
Crossref
Crossref
Trine Tramm, Guido Hennig, Marianne Kyndi, Jan Alsner, Flemming Brandt Sørensen, Simen Myhre, Therese Sørlie & Jens Overgaard. (2013) Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection. Virchows Archiv 463:6, pages 775-786.
Crossref
Crossref
Jonas Kalderstam, Patrik Edén, Pär-Ola Bendahl, Carina Strand, Mårten Fernö & Mattias Ohlsson. (2013) Training artificial neural networks directly on the concordance index for censored data using genetic algorithms. Artificial Intelligence in Medicine 58:2, pages 125-132.
Crossref
Crossref
S. Alkner, P.O. Bendahl, D. Grabau, P. Malmström, M. Fernö & L. Rydén. (2013) The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Annals of Oncology 24:5, pages 1244-1252.
Crossref
Crossref
Stefan Broselid, Benxu Cheng, Martin Sjöström, Kristina Lövgren, Heather L.P. Klug-De Santiago, Mattias Belting, Karin Jirström, Per Malmström, Björn Olde, Pär-Ola Bendahl, Linda Hartman, Mårten Fernö & L.M. Fredrik Leeb-Lundberg. (2013) G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients. Clinical Cancer Research 19:7, pages 1681-1692.
Crossref
Crossref
S. Nofech-Mozes, E.T. Vella, S. Dhesy-Thind & W.M. Hanna. (2012) Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer. Clinical Oncology 24:10, pages 684-696.
Crossref
Crossref
Rebecca Ritte, Annekatrin Lukanova, Franco Berrino, Laure Dossus, Anne Tjønneland, Anja Olsen, Thure Filskov Overvad, Kim Overvad, Françoise Clavel-Chapelon, Agnès Fournier, Guy Fagherazzi, Sabine Rohrmann, Birgit Teucher, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Sabina Sieri, Salvatore Panico, Rosario Tumino, Paolo Vineis, José Ramón Quirós, Genevieve Buckland, Maria-José Sánchez, Pilar Amiano, María-Dolores Chirlaque, Eva Ardanaz, Malin Sund, Per Lenner, Bas Bueno-de-Mesquita, Carla H van Gils, Petra HM Peeters, Sanda Krum-Hansen, Inger Torhild Gram, Eiliv Lund, Kay-Tee Khaw, Nick Wareham, Naomi E Allen, Timothy J Key, Isabelle Romieu, Sabina Rinaldi, Afshan Siddiq, David Cox, Elio Riboli & Rudolf Kaaks. (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Research 14:3.
Crossref
Crossref
Sharon Nofech-Mozes, Emily T. Vella, Sukhbinder Dhesy-Thind, Karen L. Hagerty, Pamela B. Mangu, Sarah Temin & Wedad M. Hanna. (2012) Systematic Review on Hormone Receptor Testing in Breast Cancer. Applied Immunohistochemistry & Molecular Morphology 20:3, pages 214-263.
Crossref
Crossref
László Krecsák, Tamás Micsik, Gábor Kiszler, Tibor Krenács, Dániel Szabó, Viktor Jónás, Gergely Császár, László Czuni, Péter Gurzó, Levente Ficsor & Béla Molnár. (2011) Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer. Diagnostic Pathology 6:1.
Crossref
Crossref
Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh & Bo Nordenskjöld. (2010) Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen. Breast Cancer Research and Treatment 126:2, pages 421-430.
Crossref
Crossref
Deborah M. Gregory & Patrick S. Parfrey. (2010) The Breast Cancer Hormone Receptor Retesting Controversy in Newfoundland and Labrador, Canada: Lessons for the Health System. Healthcare Management Forum 23:3, pages 114-118.
Crossref
Crossref
Karin Rennstam, Nicole McMichael, Pontus Berglund, Gabriella Honeth, Cecilia Hegardt, Lisa Rydén, Lena Luts, Pär-Ola Bendahl & Ingrid Hedenfalk. (2009) Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Breast Cancer Research and Treatment 122:2, pages 315-324.
Crossref
Crossref
Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl & Lisa Rydén. (2010) Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?. World Journal of Surgery 34:7, pages 1434-1441.
Crossref
Crossref
Olivia Pagani, Shari Gelber, Edda Simoncini, Monica Castiglione-Gertsch, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Diana Crivellari, John Collins, Jurij Lindtner, Beat Thürlimann, Martin F. Fey, Elizabeth Murray, John F. Forbes, Alan S. Coates & Aron Goldhirsch. (2008) Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93. Breast Cancer Research and Treatment 116:3, pages 491-500.
Crossref
Crossref
Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg & Cecilia Hegardt. (2008) The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Research 10:3.
Crossref
Crossref
Looket Dihge, Pär-Ola Bendahl, Dorthe Grabau, Jorma Isola, Kristina Lövgren, Lisa Rydén & Mårten Fernö. (2007) Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Breast Cancer Research and Treatment 109:2, pages 255-262.
Crossref
Crossref
Lanell M. Peterson, David A. Mankoff, Thomas Lawton, Kevin Yagle, Erin K. Schubert, Svetlana Stekhova, Allen Gown, Jeanne M. Link, Timothy Tewson & Kenneth A. Krohn. (2008)
Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and
18
F-Fluoroestradiol
. Journal of Nuclear Medicine 49:3, pages 367-374.
Crossref
Crossref
Chris Conklin, David Huntsman, Erika Yorida, Nikita Makretsov, Dmitry Turbin, John F. Bechberger, Wun Chey Sin & Christian C. Naus. (2007) Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer. Cancer Letters 255:2, pages 284-294.
Crossref
Crossref
Mervi Jumppanen, Sofia Gruvberger-Saal, Päivikki Kauraniemi, Minna Tanner, Pär-Ola Bendahl, Mikael Lundin, Morten Krogh, Pasi Kataja, Åke Borg, Mårten Fernö & Jorma Isola. (2007) Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Research 9:1.
Crossref
Crossref
Meredith M. Regan, Giuseppe Viale, Mauro G. Mastropasqua, Eugenio Maiorano, Rastko Golouh, Antonino Carbone, Bob Brown, Mart Suurküla, Gerald Langman, Luca Mazzucchelli, Stephen Braye, Piergiovanni Grigolato, Richard D. Gelber, Monica Castiglione-Gertsch, Karen N. Price, Alan S. Coates, Aron Goldhirsch & Barry Gusterson. (2006) Re-evaluating Adjuvant Breast Cancer Trials: Assessing Hormone Receptor Status by Immunohistochemical Versus Extraction Assays. JNCI: Journal of the National Cancer Institute 98:21, pages 1571-1581.
Crossref
Crossref
Sian Tovey, Barbara Dunne, Caroline J. Witton, Amanda Forsyth, Timothy G. Cooke & John M.S. Bartlett. (2005) Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer?. Clinical Cancer Research 11:13, pages 4835-4842.
Crossref
Crossref
Nai-Wen Chang, Dar-Ren Chen, Chen-Ten Wu, Bradley E. Aouizerat, Fei-Na Chen, Shin-Jer Hung, Shiuan-Huei Wang, Ming-Feng Wei & Cheng-Shyong Chang. (2005) Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan. Breast Cancer Research and Treatment 90:3, pages 257-261.
Crossref
Crossref
Daxiang Cui, Guiqiu Jin, Tianwen Gao, Tianbai Sun, Furong Tian, Giovani Gomez Estrada, Huajian Gao & Akinori Sarai. (2004) Characterization of BRCAA1 and Its Novel Antigen Epitope Identification. Cancer Epidemiology, Biomarkers & Prevention 13:7, pages 1136-1145.
Crossref
Crossref